Dementia, Cognitive decline, Disease, Alzheimer's disease and Vascular dementia are his primary areas of study. The concepts of his Dementia study are interwoven with issues in Psychiatry, Cognition, Apolipoprotein E and Gerontology. His biological study spans a wide range of topics, including Global health, Obesity, Micronutrient and Confidence interval.
The various areas that Francesco Panza examines in his Cognitive decline study include Mediterranean diet, Endocrinology, Effects of sleep deprivation on cognitive performance and Polyunsaturated fatty acid. The Disease study which covers Clinical trial that intersects with Monoclonal antibody, Family history, Placebo and Celecoxib. His Alzheimer's disease study combines topics in areas such as Allele frequency, Genome-wide association study, Pharmacology and Late onset.
His primary scientific interests are in Dementia, Disease, Internal medicine, Gerontology and Cognition. His studies in Dementia integrate themes in fields like Alzheimer's disease, Longitudinal study and Psychiatry. His Disease study combines topics from a wide range of disciplines, such as Genetics, Clinical trial, Bioinformatics and Epidemiology.
His Internal medicine research includes elements of Endocrinology, Oncology and Genotype. His Gerontology research incorporates themes from Cognitive impairment and Confidence interval. Francesco Panza combines subjects such as Presbycusis and Clinical psychology with his study of Cognition.
Francesco Panza focuses on Dementia, Disease, Cognition, Internal medicine and Gerontology. His study in Dementia focuses on Vascular dementia in particular. His Disease study incorporates themes from Clinical trial, Bioinformatics, Neuroscience and Monoclonal antibody.
His Cognition research is multidisciplinary, relying on both Presbycusis, Randomized controlled trial, Mediterranean diet, Micronutrient and Cognitive decline. His study in Internal medicine is interdisciplinary in nature, drawing from both Cross-sectional study, Psychiatric status rating scales and Drug reaction. Francesco Panza focuses mostly in the field of Gerontology, narrowing it down to topics relating to Biopsychosocial model and, in certain cases, Geriatric Depression Scale.
His main research concerns Dementia, Disease, Cognition, Gerontology and Internal medicine. His research integrates issues of Intervention, Biochemistry of Alzheimer's disease, Pathological and Neuroscience in his study of Dementia. His Disease research integrates issues from Immunology, Clinical trial, Bioinformatics and Monoclonal antibody.
His work deals with themes such as Alzheimer's disease and Aβ oligomers, which intersect with Monoclonal antibody. He has included themes like Geriatric Depression Scale, Longitudinal study and Vascular dementia in his Gerontology study. The Internal medicine study combines topics in areas such as Psychiatric status rating scales and Genotype.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults
Leandra Abarca-Gómez;Ziad A Abdeen;Zargar Abdul Hamid;Niveen M Abu-Rmeileh.
Trends in adult body-mass index in 200 countries from 1975 to 2014: A pooled analysis of 1698 population-based measurement studies with 19.2 million participants
Mariachiara Di Cesare;Mariachiara Di Cesare;James Bentham;Gretchen A Stevens;Bin Zhou.
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Jean-Charles Lambert;Jean-Charles Lambert;Jean-Charles Lambert;Carla A Ibrahim-Verbaas;Denise Harold;Adam C Naj.
Nature Genetics (2013)
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants
Bin Zhou;Yuan Lu;Kaveh Hajifathalian;James Bentham.
The Lancet (2016)
Genome-wide association study indentifies variants at CLU and CR1 associated with Alzheimer’s disease
J Lambert;S Heath;G Even;D Campion.
Nature Genetics (2009)
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.
Paul Hollingworth;Denise Harold;Rebecca Sims;Amy Gerrish.
Nature Genetics (2011)
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants
Bin Zhou;James Bentham;Mariachiara Di Cesare;Honor Bixby.
The Lancet (2017)
Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease.
Valentina Escott-Price;Céline Bellenguez;Li-San Wang;Seung-Hoan Choi.
PLOS ONE (2014)
A century of trends in adult human height
James Bentham;Mariachiara Di Cesare;Mariachiara Di Cesare;Gretchen A. Stevens;Bin Zhou.
Late-Life Depression, Mild Cognitive Impairment, and Dementia: Possible Continuum?
Francesco Panza;Vincenza Frisardi;Cristiano Capurso;Alessia D'Introno.
American Journal of Geriatric Psychiatry (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: